hUC-MSCs Attenuate Acute Graft-Versus-Host Disease through Chi3l1 Repression of Th17 Differentiation

Mesenchymal stem cells (MSCs) have already demonstrated definitive evidence of their clinical benefits in acute graft-versus-host disease (aGvHD) and other inflammatory diseases. However, the comprehensive mechanism of MSCs' immunomodulation properties has not been elucidated. To reveal their p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weijiang, Yuan, Fulin, Bai, Haitao, Liu, Yuanlin, Li, Xue, Wang, Yang, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582900/
https://www.ncbi.nlm.nih.gov/pubmed/36277038
http://dx.doi.org/10.1155/2022/1052166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582900/
https://www.ncbi.nlm.nih.gov/pubmed/36277038
http://dx.doi.org/10.1155/2022/1052166

Ejemplares similares